Medistim Balance Sheet Health
Financial Health criteria checks 6/6
Medistim has a total shareholder equity of NOK466.4M and total debt of NOK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NOK617.3M and NOK150.9M respectively. Medistim's EBIT is NOK158.2M making its interest coverage ratio -45.1. It has cash and short-term investments of NOK183.4M.
Key information
0%
Debt to equity ratio
NOK 0
Debt
| Interest coverage ratio | -45.1x |
| Cash | NOK 183.45m |
| Equity | NOK 466.42m |
| Total liabilities | NOK 150.90m |
| Total assets | NOK 617.32m |
Recent financial health updates
No updates
Recent updates
Medistim ASA (OB:MEDI) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
May 13
We Think Some Shareholders May Hesitate To Increase Medistim ASA's (OB:MEDI) CEO Compensation
May 02There May Be Reason For Hope In Medistim's (OB:MEDI) Disappointing Earnings
Mar 07
Direct Sales In China, Canada, And Sweden Will Improve Market Control
Expansion into direct markets in China, Canada, and Sweden aims for higher growth through better control and margins than distributor sales.Medistim ASA's (OB:MEDI) Shares May Have Run Too Fast Too Soon
Dec 13Medistim ASA Just Missed Earnings - But Analysts Have Updated Their Models
Oct 28Medistim ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 19Medistim ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 04One Medistim ASA (OB:MEDI) Analyst Has Been Cutting Their Forecasts
Nov 10What Does Medistim ASA's (OB:MEDI) Share Price Indicate?
Dec 14Should You Be Adding Medistim (OB:MEDI) To Your Watchlist Today?
Sep 06A Look At The Intrinsic Value Of Medistim ASA (OB:MEDI)
Jun 14Medistim (OB:MEDI) Is Increasing Its Dividend To kr3.75
Apr 21Medistim (OB:MEDI) Is Paying Out A Larger Dividend Than Last Year
Mar 31Statutory Profit Doesn't Reflect How Good Medistim's (OB:MEDI) Earnings Are
Mar 05Medistim's (OB:MEDI) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 01Medistim (OB:MEDI) Is Reinvesting To Multiply In Value
Jan 11Medistim (OB:MEDI) Might Become A Compounding Machine
Sep 29Here's Why I Think Medistim (OB:MEDI) Might Deserve Your Attention Today
Sep 07Here's What Medistim's (OB:MEDI) Strong Returns On Capital Mean
May 17Is Medistim ASA's(OB:MEDI) Recent Stock Performance Tethered To Its Strong Fundamentals?
Mar 19Medistim ASA (OB:MEDI) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 02Financial Position Analysis
Short Term Liabilities: MEDI's short term assets (NOK470.2M) exceed its short term liabilities (NOK120.2M).
Long Term Liabilities: MEDI's short term assets (NOK470.2M) exceed its long term liabilities (NOK30.7M).
Debt to Equity History and Analysis
Debt Level: MEDI is debt free.
Reducing Debt: MEDI has no debt compared to 5 years ago when its debt to equity ratio was 1.4%.
Debt Coverage: MEDI has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: MEDI has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/18 02:25 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medistim ASA is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Magnus Granerød | Beringer Finance AB |
| null null | Danske Bank |
| Geir Holom | DNB Markets |